PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT
S. Stornelli (Roma, Italy), D. Lacedonia (Roma, Italy), G. Scioscia (Roma, Italy), F. Simone (Roma, Italy), G. Lepore (Roma, Italy), R. Sabato (Roma, Italy), G. Giganti (Roma, Italy), G. Ciliberti (Roma, Italy), M. Foschino Barbaro (Roma, Italy)
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Session: Interstitial lung disease around the world
Session type: E-poster
Number: 3746
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Stornelli (Roma, Italy), D. Lacedonia (Roma, Italy), G. Scioscia (Roma, Italy), F. Simone (Roma, Italy), G. Lepore (Roma, Italy), R. Sabato (Roma, Italy), G. Giganti (Roma, Italy), G. Ciliberti (Roma, Italy), M. Foschino Barbaro (Roma, Italy). PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT. 3746
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: